Hints and tips:
Related Special Reports
...It was unbelievable,” said Alisha Alaimo, Biogen’s North America head....
...Joseph Dupont, then a vice-president at Alexion Pharmaceuticals, now owned by AstraZeneca, shared knowledge of an upcoming acquisition of Portola Pharmaceuticals with Shawn Cronin, a childhood friend and...
...The US government named 10 of the best-selling drugs as the first to face tough price regulations in a bid to slash healthcare costs, marking the biggest shake-up for the pharmaceutical industry in decades...
...The animus towards her in finance and corporate America might indicate she is having an impact despite the setbacks. The Amazon case will be a big test....
...Goldman, Bank of America, JPMorgan Chase, Morgan Stanley, Citi and UBS are on the deal....
...In May, the Pharmaceutical Supply Chain Initiative, a lobby set up by large pharmaceutical companies, said its members should stop sourcing blood from the two Asian horseshoe crab species most at risk....
...It comes after decades during which many big pharmaceutical companies lost hope and cut investment in Alzheimer’s research....
...Dan Mead, head of the investment-grade syndicate at Bank of America — a lead bookrunner on the Pfizer bond sale — said it was “not uncommon to see that for financings”....
...The FT’s US pharmaceutical correspondent Jamie Smyth helps us explore whether J&J’s use of this manoeuvre is setting a precedent for corporations to evade accountability in America....
...Goldman Sachs, JPMorgan Chase and Bank of America were lead underwriters on the listing....
Amgen to launch ‘biosimilar’ version of medicine that has generated $200bn in sales since launch
...The US drugmaker has spent almost $30bn on acquisitions over the past two years, snapping up Arena Pharmaceuticals, Biohaven Pharmaceuticals, Global Blood Therapeutics, ReViral and Trillium Therapeutics....
...But they warn that the ruling casts a shadow over the company as it seeks to remodel itself as an innovator in the pharmaceutical and medical devices sectors....
...The ruling was a significant win for the pharmaceutical companies GSK, Pfizer, Sanofi and Boehringer Ingelheim....
...“We are encouraged by these findings from Panoramic,” said Merck, which is known as MSD outside North America....
...The phase 3 trial is being led by Eisai, a Tokyo-based pharmaceutical company that has partnered US biotech Biogen to develop lecanemab....
US biotech to object to impending EU ruling on $8bn deal for cancer screening group
...But the first few that did join the company learnt that the drive to develop reduced-risk tobacco products that help people quit smoking could save more lives than many pharmaceutical products....
FDA clears jabs despite lack of human trials in effort to curb winter wave of Covid infections
...The US company’s drug tofersen targets a defective gene called SOD1, which causes about 2 per cent of cases of MND, also known as amyotrophic lateral sclerosis or ALS in North America....
Vaccine targeting BA.4/BA.5 could become first shot to win green light without human trials
...In this week’s episode, we hear from White House Covid coordinator Ashish Jha, professor of molecular medicine and cardiologist Eric Topol and the FT’s US pharmaceuticals correspondent Jamie Smyth on what...
...Peter Krause, a senior research scientist at the Yale School of Public Health, said the proliferation of wild deer that carry ticks across North America is thought to be the main reason for the disease’s...
...The publicly traded real estate investment trust operates 41.9mn square feet of space in North America, with millions more in development. Its market capitalisation stands at $24bn....
Protein-based vaccine is an alternative to mRNA technology used by BioNTech/Pfizer and Moderna
International Edition